Neuronetics, Inc. (STIM)

Neuronetics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	151.64	149.16	74.89	71.35	65.21	55.31
Revenue Growth	69.52%	99.17%	4.96%	9.42%	17.89%	12.32%
Gross Profit Gross Profit Growth	72.72	72.31	54.16	51.71	49.72	43.66
Operating Income Operating Income Growth	-29.42	-31.44	-34.56	-30.55	-35.11	-27.56
Net Income Net Income Growth	-37.11	-39	-43.71	-30.19	-37.16	-31.19
Earnings Per Share EPS Growth	-0.54	-0.59	-1.38	-1.05	-1.38	-1.22
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Medical Device Medical Device Growth	61.79	62.18	70.45	71.35
Clinic Services Market Clinic Services Market Growth	89.85	86.98	4.45	-
Total Total Growth	151.64	149.16	74.89	71.35

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	13.21	28.13	18.46	59.68	70.34	94.14
Total Debt Total Debt Growth	85.39	90.3	82.63	62.47	39.75	39.54
Net Cash (Debt) Net Cash Growth	-72.17	-62.17	-64.17	-2.8	30.6	54.6
Net Cash Growth	-	-	-	-	-43.96%	414.00%
Net Cash Per Share Net Cash Per Share Growth	-1.06	-0.94	-2.02	-0.10	1.14	2.14

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-12.8	-20.37	-31	-32.04	-30.74	-27.98
Capital Expenditures CapEx Growth	-0.78	-0.8	-1.47	-2.37	-3.27	-2.35
Free Cash Flow Free Cash Flow Growth	-13.58	-21.18	-32.46	-34.41	-34.01	-30.34
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	47.96%	48.48%	72.32%	72.47%	76.26%	78.93%
Operating Margin	-19.40%	-21.08%	-46.15%	-42.82%	-53.85%	-49.83%
Pretax Margin	-26.16%	-27.20%	-65.20%	-58.54%	-63.74%	-57.80%
Profit Margin	-24.55%	-26.24%	-58.39%	-42.31%	-56.99%	-56.39%
FCF Margin	-8.96%	-14.20%	-43.35%	-48.22%	-52.15%	-54.85%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PS Ratio	1.07	0.64	1.20	1.18	2.87	2.13

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: May 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error